[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352504-105":59,"doc-detail-352504-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","fibronectin-1-fn1-rearranged-mesenchymal-neoplasms-an-updated-review","Fibronectin 1 (FN1)-rearranged Mesenchymal Neoplasms: An Updated Review","","Fibronectin 1 (FN1), encoded on chromosome 2q35, is a key extracellular matrix glycoprotein. Multiple chondroid matrix-producing tumors share histologic overlap and commonly harbor FN1 rearrangements, including soft tissue chondroma, synovial chondromatosis, calcifying aponeurotic fibroma, calcified chondroid mesenchymal neoplasm, and phosphaturic mesenchymal tumor. Over the last decade, FN1 fusions have also been reported in lipofibromatosis and inflammatory myofibroblastic tumor. The review summarizes updated clinical, histological, and molecular genetic features and their relationships within the WHO classification.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/fibronectin-1-fn1-rearranged-mesenchymal-neoplasms-an-updated-review/352504/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/fibronectin-1-fn1-rearranged-mesenchymal-neoplasms-an-updated-review/352504.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the role of FN1 and where is it located in the genome?","Question",{"text":112,"@type":113},"FN1 is located on chromosome 2q35 and encodes fibronectin, a high molecular weight glycoprotein of the extracellular matrix. It is involved in cellular processes such as adhesion and migration.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which tumors are associated with FN1 rearrangements?",{"text":117,"@type":113},"FN1 rearrangements are reported in several chondroid matrix-producing tumors, including soft tissue chondroma, synovial chondromatosis, calcifying aponeurotic fibroma, calcified chondroid mesenchymal neoplasm, and phosphaturic mesenchymal tumor. FN1 fusions have also been described in lipofibromatosis and inflammatory myofibroblastic tumor.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the WHO classification describe FN1-rearranged lesions?",{"text":121,"@type":113},"The current WHO classification suggests that FN1-rearranged lesions are typically benign or intermediate. Malignant transformation is described as extremely rare, with synovial chondromatosis as an exception.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352504,1790484857,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","doi: 10.21873/cgp.20569  \nReview  \nFibronectin 1 (FN1)-rearranged Mesenchymal Neoplasms: An Updated Review  \nJUN NISHIO1, YOSHIRO CHIJIIWA1, YUKI SHINOHARA1, MIKIKO AOKI2 and KAORI KOGA2  \n1Section of Orthopaedic Surgery, Department of Medicine, Fukuoka Dental College, Fukuoka, Japan; 2 Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan  \nAbstract  \nFibronectin 1 (FN1), located on chromosome 2q35, encodes fibronectin, a high molecular weight glycoprotein of the extracellular matrix. Several histologically overlapping chondroid matrix-producing tumors are known to harbor FN1 rearrangements, including soft tissue chondroma, synovial chondromatosis, calcifying aponeurotic fibroma, calcified chondroid mesenchymal neoplasm and phosphaturic mesenchymal tumor. Over the past 10 years, fusions involving the FN1 gene have also been identified in other mesenchymal neoplasms such as lipofibromatosis and inflammatory myofibroblastic tumor. The current World Health Organization Classification of Soft Tissue and Bone Tumors suggests that FN1-rearranged lesions are typically benign or intermediate. This review provides an updated overview of the clinical, histological and molecular genetic features ofFN1-rearranged mesenchymal neoplasms and discusses their relationships with one another.  \nKeywords: FN1, soft tissue chondroma, synovial chondromatosis, calcifying aponeurotic fibroma, calcified chondroid mesenchymal neoplasm, phosphaturic mesenchymal tumor, lipofibromatosis, inflammatory myofibroblastic tumor, review.  \nIntroduction  \nFibronectin 1 (FN1), located on chromosome 2q35, is a protein coding gene and encodes fibronectin that is involved in a wide range of physiological processes, including cell adhesion and migration (1, 2). FN1 rearrangements have  \nbeen implicated in the pathogenesis ofa particular group of soft-tissue and bone tumors. This group of so called “FN1-rearranged mesenchymal neoplasms” has been increasing in recent years, mainly consisting of chondroid matrixproducing tumors such as soft tissue chondroma (STC) (3), synovial chondromatosis (SC) (3), calcifying aponeurotic  \n✉ Jun Nishio, Section of Orthopaedic Surgery, Department of Medicine, Fukuoka Dental College, 2-15-1 Tamura, Sawara-ku,  \nFukuoka 814-0193, Japan. Tel: +81 928010411, Fax: +81 928010735, [e-mail: nishio@fdcnet.ac.jp](e-mail: nishio@fdcnet.ac.jp)  \nReceived November 6, 2025 | Revised November 26, 2025 | Accepted December 29, 2025  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2026 The Author(s) . Anticancer Research is published by the International Institute of Anticancer Research.  \nTable I. Clinicopathological and molecular characteristics of FN1-rearranged mesenchymal neoplasms.  \n\n| Entity | Age/sex | Predilection site | Prognosis | Histology/IHC features | FN1 fusion partners |\n| --- | --- | --- | --- | --- | --- |\n| STC | Middle-aged adults/slight male predominance | Hands and feet | LRR:15-20%;\u003Cbr>no malignant\u003Cbr>transformation | Well-circumscribed margins. Chondroid matrix with/ without coarse calcification. Mature chondrocytes, osteoclast-type giant cells (variable) . S100+, EGF+, ERG+ . | FGFR1, FGFR2 |\n| SC | Young and middle-aged adults/male predominance | Knee joint | LRR:15-20%;\u003Cbr>malignant\u003Cbr>transformation:\u003Cbr>1-10% | Well-circumscribed margins. Mature hyaline cartilage with frequent calcification or endochondral ossification. | ACVR2A, NFATC2 |\n| CAF | Children and adolescents/ male predominance | Hands and feet | LRR: \u003C53%;\u003Cbr>malignant\u003Cbr>transformation;\u003Cbr>extremely rare\u003Cbr>(only one case) | Mature round to polygonal chondrocytes. S100+ . Infiltrative margins. Foci of calcification and chondroid areas.\u003Cbr>Bland spindle cells, epithelioid fibroblasts, chondrocyte-like cells, osteoclast-type giant cells. S100 (variable), SMA (variable), MSA (vari","cbCaiheDKNBWBkjw","https://ap.wps.com/l/cbCaiheDKNBWBkjw","pdf",2898365,13,"English","# Introduction\n# Chondroid Matrix-producing Tumors\n## Entity overview: STC, SC, CAF, CCMN and PMT\n# Clinicopathological and molecular characteristics\n## Table I summary and fusion partners\n# Relationships among FN1-rearranged lesions","[{\"question\":\"What is the role of FN1 and where is it located in the genome?\",\"answer\":\"FN1 is located on chromosome 2q35 and encodes fibronectin, a high molecular weight glycoprotein of the extracellular matrix. It is involved in cellular processes such as adhesion and migration.\"},{\"question\":\"Which tumors are associated with FN1 rearrangements?\",\"answer\":\"FN1 rearrangements are reported in several chondroid matrix-producing tumors, including soft tissue chondroma, synovial chondromatosis, calcifying aponeurotic fibroma, calcified chondroid mesenchymal neoplasm, and phosphaturic mesenchymal tumor. FN1 fusions have also been described in lipofibromatosis and inflammatory myofibroblastic tumor.\"},{\"question\":\"How does the WHO classification describe FN1-rearranged lesions?\",\"answer\":\"The current WHO classification suggests that FN1-rearranged lesions are typically benign or intermediate. Malignant transformation is described as extremely rare, with synovial chondromatosis as an exception.\"}]","Fibronectin 1 (FN1)-rearranged Mesenchymal Neoplasms: An Updated Review | PDF",1790100003,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e858550e7976bde38b5b7aad16e33274.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8eccb4cfead033c216e5c410a6c1c730.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6379d96f06fc14d7579993052fb16e1d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a21ff12407ca65b25aebf0f4cac204fe.webp",980,1306]